The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted th ...

New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one ...

TRIPLE-NEGATIVE breast cancer (TNBC) remains one of the most aggressive subtypes of breast cancer, with limited targeted ...

Atezolizumab enhances long-term outcomes in triple-negative breast cancer, revealing promising insights on ctDNA as a ...

Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer vaccine clinical trials in various stages in the U.S., some in phase II and III.

Characteristics of the tumor microenvironment are likely to contribute to the aggressiveness of triple-negative breast cancer (TNBC) and the extremely poor prognosis of those who suffer it. By ...

No one wants to hear the words: "You have cancer." But about 1 in 8 American women will learn they have breast cancer, according to the Centers for Disease Control and Prevention. "Breast ...

For centuries, the European honeybee has given people honey, wax, propolis, and even venom. Now, scientists are looking ...

A young teacher has told of her devastating cancer diagnosis after doctors initially dismissed her concerns, putting her 'lumpy boobs' down to her young age.

BU researchers have now discovered that exosomes—messenger nanovesicles  that carry proteins, RNA, and other molecules to other cells—released into the blood by different organs and tissues in obese, ...

Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...

In an emotional whirlwind across three years, Hannah Curran found love, faced a cancer diagnosis, and married her soulmate on ...